Lynx1 Capital Management LP Allakos Inc. Transaction History
Lynx1 Capital Management LP
- $257 Million
- Q4 2024
A detailed history of Lynx1 Capital Management LP transactions in Allakos Inc. stock. As of the latest transaction made, Lynx1 Capital Management LP holds 3,628,144 shares of ALLK stock, worth $907,036. This represents 1.7% of its overall portfolio holdings.
Number of Shares
3,628,144Holding current value
$907,036% of portfolio
1.7%About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $21.2M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...